Models
Source: Visible Alpha consensus via S&P Xpressfeed · Consensus as of 2026-07-14 · generated 2026-07-17.
Model trust
This reads as a broad, timely consensus rather than a narrow or stale one.
Base currency: USD · VA scales normalized from Abs, M; item currencies and units retained · Coverage depth and vintage; broker count is the maximum represented.
| Brokers | Line items | Last revision |
|---|---|---|
| 14 | 314 | 2026-07-14 |
Operating KPIs
Base currency: USD · VA scales normalized from Abs, M; item currencies and units retained · FY-1A / FY0E / FY+1E; broker count shown per KPI.
| Operating KPI | Source | FY-1A | FY0E | FY+1E | Brokers |
|---|---|---|---|---|---|
| General and administrative expenses | CD | 2,952,707.24bn Amount | 2,906,178.34bn Amount | 3,092,677.69bn Amount | 14 |
| Medical care costs | CD | 39,071,602.51bn Amount | 38,951,976.71bn Amount | 42,418,451.87bn Amount | 14 |
| Premium revenue | CD | 42,779,644.46bn Amount | 42,105,377.33bn Amount | 46,042,367.97bn Amount | 14 |
| Premium tax expenses | CD | 1,724,224.62bn Amount | 2,023,000.07bn Amount | 2,033,030.93bn Amount | 14 |
| Depreciation and amortization | CD | 198,992.73bn Amount | 166,937.45bn Amount | 179,809.03bn Amount | 13 |
| General and Administrative Expenses - Operating | CD | 2,923,424.96bn Amount | 2,876,538.47bn Amount | 3,098,461.35bn Amount | 13 |
| General and administrative ratio - Operating(%) | CD | 6.5% | 6.4% | 6.3% | 13 |
| General and administrative ratio(%) | CD | 6.6% | 6.5% | 6.4% | 13 |
| Medical cost ratio - Life and Health Insurance(%) | CD | 91.3% | 92.5% | 92.1% | 13 |
| Medical cost ratio(%) | CD | 91.3% | 92.5% | 92.1% | 13 |
| Medical margin | CD | 3705588222.4% | 3158867777.5% | 3659974284.4% | 13 |
| Premium Revenue - Marketplace | CD | 4,576,880.29bn Amount | 2,666,145.20bn Amount | 2,609,649.79bn Amount | 13 |
P&L bridge
Base currency: USD · VA scales normalized from Abs, M; item currencies and units retained · Margins are derived against revenue; YoY compares adjacent fiscal columns; broker count shown per line.
| P&L line | FY-1A | FY0E | FY+1E | Brokers |
|---|---|---|---|---|
| Revenue | 45,030,856.77bn Amount | 44,588,465.14bn Amount (-1.0% YoY) | 48,554,889.24bn Amount (8.9% YoY) | 14 |
| Gross Profit | 5,955,852.13bn Amount (13.2% margin) | 5,636,488.43bn Amount (12.6% margin; -5.4% YoY) | 6,136,437.37bn Amount (12.6% margin; 8.9% YoY) | 14 |
| Ebitda | 1,220,414.75bn Amount (2.7% margin) | 682,445.22bn Amount (1.5% margin; -44.1% YoY) | 973,223.29bn Amount (2.0% margin; 42.6% YoY) | 12 |
| Operating Income | 1,093,858.88bn Amount (2.4% margin) | 522,112.47bn Amount (1.2% margin; -52.3% YoY) | 859,378.39bn Amount (1.8% margin; 64.6% YoY) | 11 |
| Net Income | 742,008.42bn Amount (1.6% margin) | 263,464.94bn Amount (0.6% margin; -64.5% YoY) | 480,672.20bn Amount (1.0% margin; 82.4% YoY) | 14 |
| Eps | 13.95 Amount | 5.17 Amount (-62.9% YoY) | 9.94 Amount (92.1% YoY) | 14 |
Consensus dispersion
The debate is therefore about how deep and durable the earnings trough proves, not about premium growth or the reported cost ratio.
Base currency: USD · VA scales normalized from Abs, M; item currencies and units retained · Top high-low spreads relative to absolute mean; requires at least 3 brokers.
| Line item | Period | Mean | Min | Q1 | Q3 | Max | Spread / mean | Brokers |
|---|---|---|---|---|---|---|---|---|
| EPS Diluted, Applicable to common stockholders($) | 4QFY-2026 | 0.11 Amount | -1.15 Amount | -0.07 Amount | 0.44 Amount | 0.85 Amount | 1892.6% | 14 |
| Net income/(loss), Applicable to common stockholders | 4QFY-2026 | 5,415.86bn Amount | -58,780.73bn Amount | -3,455.96bn Amount | 22,248.10bn Amount | 43,374.80bn Amount | 1886.2% | 14 |
| EPS Diluted, Applicable to common stockholders($) | 4QFY-2025 | 0.35 Amount | -0.33 Amount | 0.35 Amount | 0.42 Amount | 0.86 Amount | 339.1% | 12 |
| Net income/(loss), Applicable to common stockholders | 4QFY-2025 | 18,036.50bn Amount | -16,882.48bn Amount | 17,723.69bn Amount | 22,072.52bn Amount | 43,860.08bn Amount | 336.8% | 12 |
| Operating income/(loss) | 4QFY-2026 | 60,115.85bn Amount | -30,146.79bn Amount | 54,469.81bn Amount | 81,828.32bn Amount | 101,726.30bn Amount | 219.4% | 11 |
| Depreciation and amortization | 1QFY-2026 | 52,179.17bn Amount | 35,854.85bn Amount | 45,104.96bn Amount | 50,222.90bn Amount | 107,500.00bn Amount | 137.3% | 12 |
Quarterly path
Base currency: USD · VA scales normalized from Abs, M; item currencies and units retained · Next four supplied quarters; final column is maximum broker coverage in the row.
| Quarter | General and administrative expenses | Medical care costs | Premium revenue | Premium tax expenses | Depreciation and amortization | Total revenue | EPS Diluted, Applicable to common stockholders($) | Broker coverage |
|---|---|---|---|---|---|---|---|---|
| 3QFY-2026 | 688,498.98bn Amount | 9,602,838.09bn Amount | 10,356,524.10bn Amount | 498,747.53bn Amount | 41,875.33bn Amount | 10,972,436.66bn Amount | 1.27 Amount | 14 |
| 4QFY-2026 | 740,368.84bn Amount | 10,581,440.72bn Amount | 11,303,521.10bn Amount | 542,415.13bn Amount | 43,529.23bn Amount | 11,964,380.95bn Amount | 0.11 Amount | 14 |
| 1QFY-2027 | 800,985.96bn Amount | 10,207,405.38bn Amount | 11,195,513.01bn Amount | 495,546.60bn Amount | 44,208.91bn Amount | 11,810,959.59bn Amount | 3.16 Amount | 13 |
| 2QFY-2027 | 753,578.44bn Amount | 10,447,532.79bn Amount | 11,344,085.32bn Amount | 483,877.07bn Amount | 45,782.89bn Amount | 11,949,102.00bn Amount | 2.53 Amount | 13 |
38 stale period values omitted; 2 line items fully removed.